Aduro Biotech Announces First Quarter 2015 Financial Results
28. Mai 2015 16:00 ET
|
Chinook Therapeutics, Inc.
Established major $750M collaboration with Novartis for STING in oncology
Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...